Action Type |
ASCA Status |
Effective Start Date
|
Biocompatibility Test Method
|
Recognition Number
|
Designation Number |
Exclusions |
| Accredit |
Accreditation Granted |
04/12/2021 |
|
1-105
|
80601-2-72 First edition 2015-04-11
|
|
| Delete |
Administrative Deletion |
07/15/2022 |
|
1-138
|
80601-2-74 First edition 2017-05
|
|
| Accredit |
Accreditation Granted |
04/12/2021 |
|
1-139
|
80601-2-61 Second edition 2017-12 (Corrected version 2018-02)
|
|
| Accredit |
Accreditation Granted |
04/12/2021 |
|
1-140
|
80601-2-55 Second edition 2018-02
|
|
| Delete |
Administrative Deletion |
10/04/2022 |
|
1-141
|
80601-2-13 First edition 2011-08-11
|
|
| Accredit |
Accreditation Granted |
10/11/2022 |
|
1-146
|
80601-2-12 Second edition 2020-02
|
|
| Accredit |
Accreditation Granted |
10/11/2022 |
|
1-98
|
80601-2-12 First edition 2011-04-15
|
|
| Accredit |
Accreditation Granted |
04/12/2021 |
|
12-268
|
60601-2-22 Edition 3.1 2012-10
|
|
| Accredit |
Accreditation Granted |
04/12/2021 |
|
12-293
|
60601-2-37 Edition 2.1 2015
|
|
| Accredit |
Accreditation Granted |
04/12/2021 |
|
17-16
|
60601-2-10 Edition 2.1 2016-04
|
|
| Accredit |
Accreditation Granted |
04/12/2021 |
|
19-14
|
60601-1-11 Edition 2.0 2015-01
|
|
| Accredit |
Accreditation Granted |
11/22/2022 |
|
19-15
|
60601-1-12 Edition 1.0 2014-06
|
|
| Accredit |
Accreditation Granted |
04/12/2021 |
|
19-34
|
61010-1 Edition 3.1 2017-01 CONSOLIDATED VERSION
|
|
| Accredit |
Accreditation Granted |
11/22/2022 |
|
19-37
|
60601-1-10 Edition 1.2 2020-07 CONSOLIDATED VERSION
|
|
| Accredit |
Accreditation Granted |
04/12/2021 |
|
19-38
|
60601-1-11 Edition 2.1 2020-07 CONSOLIDATED VERSION
|
|
| Accredit |
Accreditation Granted |
11/22/2022 |
|
19-39
|
60601-1-12 Edition 1.1 2020-07 CONSOLIDATED VERSION
|
|
| Accredit |
Accreditation Granted |
10/11/2022 |
|
19-4
|
ES60601-1:2005/(R)2012 and A1:2012, C1:2009/(R)2012 and A2:2010/(R)2012 (Consolidated Text)
|
|
| Accredit |
Accreditation Granted |
10/11/2022 |
|
19-46
|
ES60601-1:2005/(R)2012 & A1:2012, C1:2009/(R)2012 & A2:2010/(R)2012 (Cons. Text) [Incl. AMD2:2021]
|
|
| Accredit |
Accreditation Granted |
10/11/2022 |
|
19-47
|
HA60601-1-11:2015 [Including AMD1:2021]
|
|
| Accredit |
Accreditation Granted |
11/22/2022 |
|
19-9
|
60601-1-10 Edition 1.1 2013-11
|
|
| Delete |
Administrative Deletion |
07/14/2022 |
Closed Patch Sensitization |
2-174
|
10993-10 Third Edition 2010-08-01
|
|
| Delete |
Administrative Deletion |
07/14/2022 |
Dermal Irritation |
2-174
|
10993-10 Third Edition 2010-08-01
|
|
| Delete |
Administrative Deletion |
07/14/2022 |
Intracutaneous Reactivity Irritation |
2-174
|
10993-10 Third Edition 2010-08-01
|
|
| Delete |
Administrative Deletion |
07/14/2022 |
Guinea Pig Maximization Sensitization |
2-174
2-256
|
10993-10 Third Edition 2010-08-01
F720-17
|
|
| Accredit |
Accreditation Granted |
04/12/2021 |
|
3-102
|
60601-2-31 Edition 2.1 2011-09
|
|
| Delete |
Administrative Deletion |
05/23/2023 |
|
3-126
|
60601-2-27 Edition 3.0 2011-03
|
|
| Accredit |
Accreditation Granted |
04/12/2021 |
|
4-262
|
80601-2-60 Edition 2.0 2019-06
|
|
| Accredit |
Accreditation Granted |
04/12/2021 |
|
5-131
|
60601-1-8 Edition 2.2 2020-07 CONSOLIDATED VERSION
|
|
| Accredit |
Accreditation Granted |
04/12/2021 |
|
5-132
|
60601-1-6 Edition 3.2 2020-07 CONSOLIDATED VERSION
|
|
| Accredit |
Accreditation Granted |
04/12/2021 |
|
5-76
|
60601-1-8 Edition 2.1 2012-11
|
|
| Accredit |
Accreditation Granted |
04/12/2021 |
|
5-89
|
60601-1-6 Edition 3.1 2013-10
|
|
| Accredit |
Accreditation Granted |
10/11/2022 |
|
6-389
|
60601-2-2 Edition 6.0 2017-03
|
|
| Accredit |
Accreditation Granted |
04/12/2021 |
|
6-390
|
80601-2-35 Edition 2.1 2016-04
|
|
| Accredit |
Accreditation Granted |
04/12/2021 |
|
9-114
|
60601-2-18: Edition 3.0 2009-08
|
|